{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:23Z","timestamp":1791357443105,"version":"4.3.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pnpbp.2019.109643","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:52:41Z","timestamp":1557251561000},"page":"109643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Zolpidem stimulant effect: Induced mania case report and systematic review of cases"],"prefix":"10.1016","volume":"94","author":[{"given":"M.","family":"Sabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sentissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4172\/Neuropsychiatry.1000120","article-title":"Misuse of Zolpidem to get high: a distinguished mystery","volume":"6","author":"Ahmadi","year":"2016","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.pnpbp.2019.109643_bb0015","series-title":"Zolpidem (Edluar\u00ae, Stilnox\u00ae et g\u00e9n\u00e9riques): nouvelles conditions de prescription et d\u00e9livrance","author":"ANSM","year":"2017"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0004867415582232","article-title":"Treatment refractory chronic catatonia responsive to zolpidem challenge","volume":"50","author":"Bastiampillai","year":"2016","journal-title":"Aust. NZ J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109643_bb0025","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"Bmj"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109643_bb0030","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaneurol.2017.1133","article-title":"Zolpidem for the treatment of neurologic disorders: a systematic review","volume":"74","author":"Bomalaski","year":"2017","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/mol.52.4.676","article-title":"Residues at positions 206 and 209 of the alpha1 subunit of gamma-aminobutyric AcidA receptors influence affinities for benzodiazepine binding site ligands","volume":"52","author":"Buhr","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/srep28674","article-title":"Zolpidem is a potent stoichiometry-selective modulator of alpha1beta3 GABAA receptors: evidence of a novel benzodiazepine site in the alpha1-alpha1 interface","volume":"6","author":"Che Has","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0045","first-page":"330","article-title":"Zolpidem withdrawal delirium, seizure, and acute psychosis: case reports and literature review","volume":"16","author":"Chien","year":"2011","journal-title":"J. Subst. Abus."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109643_bb0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2125.2007.03028.x","article-title":"Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects","volume":"65","author":"Cubala","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109643_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/10550490600860643","article-title":"Zolpidem and dextromoramide abuse with increased metabolism","volume":"15","author":"Djezzar","year":"2006","journal-title":"Am. J. Addict."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109643_bb0060","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2019.109643_bb0065","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1038\/tp.2013.64","article-title":"Expression of GABAA alpha2-, beta1- and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder","volume":"3","author":"Fatemi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109643_bb0070","series-title":"Risk of Next-Morning Impairment after Use of Insomnia Drugs; FDA Requires Lower Recommended Doses for Certain Drugs Containing Zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)","author":"FDA","year":"2013"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109643_bb0075","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00213-014-3457-x","article-title":"The behavioral pharmacology of zolpidem: evidence for the functional significance of alpha1-containing GABA(A) receptors","volume":"231","author":"Fitzgerald","year":"2014","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109643_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S0033291700007911","article-title":"Cognitive impairment in long-term benzodiazepine users","volume":"18","author":"Golombok","year":"1988","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0090","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109643_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jcph.220","article-title":"Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration","volume":"54","author":"Greenblatt","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00004850-199807000-00002","article-title":"Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases","volume":"13","author":"Hajak","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.109643_bb0105","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data","volume":"98","author":"Hajak","year":"2003","journal-title":"Addiction"},{"issue":"35","key":"10.1016\/j.pnpbp.2019.109643_bb0110","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1074\/jbc.RA118.002792","article-title":"Cell surface expression of homomeric GABAA receptors depends on single residues in subunit transmembrane domains","volume":"293","author":"Hannan","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109643_bb0115","first-page":"1006","article-title":"Zolpidem dependence, abuse and withdrawal: a case report","volume":"18","author":"Heydari","year":"2013","journal-title":"J. Res. Med. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1176\/appi.psy.45.1.88","article-title":"Zolpidem-induced delirium with mania in an elderly woman","volume":"45","author":"Hill","year":"2004","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0125","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","article-title":"Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia","volume":"59","author":"Holm","year":"2000","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10550490802139168","article-title":"A case of zolpidem dependence successfully detoxified with clonazepam","volume":"17","author":"Jana","year":"2008","journal-title":"Am. J. Addict."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109643_bb0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.psym.2011.01.023","article-title":"Zolpidem-induced mania in a patient with schizoaffective disorder","volume":"52","author":"Kinnan","year":"2011","journal-title":"Psychosomatics"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109643_bb0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0033291700003214","article-title":"Computed axial brain tomography in long-term benzodiazepine users","volume":"14","author":"Lader","year":"1984","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/136515002761581036","article-title":"A zolpidem and cocaine abuse case report","volume":"6","author":"Liappas","year":"2002","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0269881103017001723","article-title":"Zolpidem dependence case series: possible neurobiological mechanisms and clinical management","volume":"17","author":"Liappas","year":"2003","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109643_bb0160","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.clinthera.2014.09.017","article-title":"Hypnotics in insomnia: the experience of zolpidem","volume":"36","author":"MacFarlane","year":"2014","journal-title":"Clin. Ther."},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109643_bb0165","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.18203\/2319-2003.ijbcp20175222","article-title":"Zolpidem dependence with frontal lobe syndrome: a case report","volume":"6","author":"Majumder","year":"2017","journal-title":"Int. J. Basic Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109643_bb0170","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1592\/phco.24.13.1177.38089","article-title":"Paradoxical reactions to benzodiazepines: literature review and treatment options","volume":"24","author":"Mancuso","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0175","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4088\/JCP.09l05240gry","article-title":"Command hallucinations with self-stabbing associated with zolpidem overdose","volume":"71","author":"Manfredi","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109643_bb0180","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1586\/ern.12.98","article-title":"Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?","volume":"12","author":"McNamara","year":"2012","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0185","article-title":"Zolpidem dependence: a case report","volume":"17","author":"Mohapatra","year":"2014","journal-title":"East. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109643_bb0190","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-1781(93)90037-H","article-title":"Computed axial brain tomograms in long-term benzodiazepine users","volume":"48","author":"Moodley","year":"1993","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109643_bb0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/alcalc\/36.5.357","article-title":"Frontal lobe changes in alcoholism: a review of the literature","volume":"36","author":"Moselhy","year":"2001","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0205","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00414-014-0997-x","article-title":"Sleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour","volume":"129","author":"Paulke","year":"2015","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0215","first-page":"37","article-title":"\u00c9valuation de la d\u00e9pendance aux benzodiaz\u00e9pines \u00e0 l'aide d'une \u00e9chelle cognitive","volume":"131","author":"Pelissolo","year":"1996","journal-title":"Synapse"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109643_bb0220","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0090-9556(25)06824-2","article-title":"Oxidative metabolism of zolpidem by human liver cytochrome P450S","volume":"23","author":"Pichard","year":"1995","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109643_bb0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.yic.0000166404.41850.b4","article-title":"Dependence on zolpidem: two case reports of detoxification with flumazenil infusion","volume":"20","author":"Quaglio","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0230","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1037\/1064-1297.8.1.22","article-title":"Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans","volume":"8","author":"Rush","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.109643_bb2000","series-title":"Ambien\u00ae (zolpidem tartrate). NDA 19908 FDA SLR 027 Approved labeling 4.23.08","author":"Sanofi-Aventis Corp.","year":"2008"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0240","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1017\/S0033291700000660","article-title":"Enlargement of cerebrospinal fluid spaces in long-term benzodiazepine abusers","volume":"17","author":"Schmauss","year":"1987","journal-title":"Psychol. Med."},{"issue":"Suppl. 20","key":"10.1016\/j.pnpbp.2019.109643_bb0245","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109643_bb0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)01118-8","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109643_bb0255","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004850-199909000-00004","article-title":"Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies","volume":"14","author":"Soldatos","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109643_bb0260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hup.470100417","article-title":"Zopiclone abuse in South Wales: three case reports","volume":"10","author":"Sullivan","year":"1993","journal-title":"Human Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0265","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pnpbp.2007.11.001","article-title":"Extensive craving in high dose zolpidem dependency","volume":"32","author":"Svitek","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109643_bb0270","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.dld.2014.04.007","article-title":"Paradoxical reaction to midazolam in patients undergoing endoscopy under sedation: incidence, risk factors and the effect of flumazenil","volume":"46","author":"Tae","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2125.2007.02861.x","article-title":"Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey","volume":"64","author":"Victorri-Vigneau","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2125.1999.00953.x","article-title":"Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations","volume":"48","author":"Von Moltke","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109643_bb0285","first-page":"76","article-title":"Zolpidem dependence and withdrawal seizure\u2013report of two cases","volume":"23","author":"Wang","year":"2011","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0290","series-title":"WHO Expert Committee on Drug Dependence: Thirty-First Report","author":"WHO","year":"1998"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5664\/jcsm.6452","article-title":"Spontaneous adverse event reports associated with Zolpidem in the United States 2003\u20132012","volume":"13","author":"Wong","year":"2017","journal-title":"J. Clin. Sleep Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109643_bb0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pediatrneurol.2005.08.002","article-title":"Acute infantile encephalopathy predominantly affecting the frontal lobes","volume":"34","author":"Yamanouchi","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.pnpbp.2019.109643_bb0305","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109643_bb0310","article-title":"Sleep and sedative states induced by targeting the histamine and noradrenergic systems","volume":"12","author":"Yu","year":"2018","journal-title":"Front. Neural Circ."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618308595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618308595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:46:32Z","timestamp":1759520792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618308595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":62,"alternative-id":["S0278584618308595"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109643","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zolpidem stimulant effect: Induced mania case report and systematic review of cases","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109643"}}